Latest Articles

Publication Date
Indications and Efficacy of Progestogen-Monotherapy as Menopause Hormone Therapy: A Narrative Review.

Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen …

Published: June 25, 2026, midnight
Boomer GP Insists Endometriosis Is Very Rare And Maybe It's Your Diet That Doesn't Agree With You Sweetheart - The Betoota Advocate

Boomer GP Insists Endometriosis Is Very Rare And Maybe It's Your Diet That Doesn't Agree With You Sweetheart The Betoota Advocate

Published: June 24, 2026, 3:23 a.m.
Revisiting endometriosis management: Polyphenols as alternative therapeutic candidates.

Endometriosis (EM) is a common gynecological disorder imposing a considerable burden on the quality of life of women through chronic pain, infertility, and other clinical manifestations. The effectiveness of management …

Published: June 24, 2026, midnight
Doctor Exposes Shocking Studies On Women’s Health, And People Are Absolutely Furious - AOL.com

Doctor Exposes Shocking Studies On Women’s Health, And People Are Absolutely Furious AOL.com

Published: June 23, 2026, 11:50 p.m.
The Bodies We Mourn, The Selves We Become: Endometriosis, Queerness, and Grief - Endometriosis Foundation of America

The Bodies We Mourn, The Selves We Become: Endometriosis, Queerness, and Grief Endometriosis Foundation of America

Published: June 23, 2026, 2:30 p.m.
Hyaluronic Acid Enriched Medium for Embryo Transfer: A Systematic Review and Meta-analysis.

This systematic review and meta-analysis of randomized controlled trials (RCTs) evaluated whether the use of hyaluronic acid (HA)-enriched medium for embryo transfer (ET) improves live birth rates in in-vitro fertilization …

Published: June 23, 2026, midnight
Incidence and remission of endometriosis in Germany based on prevalence data from 35 million patients from the statutory health insurance.

Endometriosis is a chronic gynecological disease that can potentially develop as early as birth and can restrict the life of the patient. With the increasing prevalence of endometriosis in Germany, …

Published: June 23, 2026, midnight
Evaluation of the use of dienogest in women with deep endometriosis and ovarian endometrioma: a retrospective cohort study.

The aim of this study was to evaluate the use of dienogest in the treatment of deep endometriosis and ovarian endometrioma.

Published: June 22, 2026, midnight
Serum Interleukin-6 Levels in Endometriosis and Endometriosis-Associated Ovarian Cancer: A Systematic Review and Meta-Analysis Demonstrating a Biological Gradient.

This study quantifies serum/plasma interleukin-6 levels across the healthy-non-endometriosis benign-endometriosis-ovarian cancer spectrum, focusing on pooled geometric means stratified by control type.

Published: June 21, 2026, midnight
The role of anti-Müllerian hormone as a therapeutic agent to preserve the ovarian follicle pool during chemotherapy.

Cancer treatments can deplete the ovarian follicle reserve, causing infertility and early menopause, with subsequent decline in cardiovascular, cognitive, and overall women's health. Medical measures to prevent this chemotherapy-induced ovarian …

Published: June 20, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!